Clinical Results

Flyte is backed by strong clinical evidence - more than most conservative therapy devices

Flyte is designed to help women who experience mild, moderate or severe stress urinary incontinence (SUI). Whether you have occasional "nuisance" leaks, or if your SUI is more severe and you're considering surgery,  Flyte is the clinically proven solution.

Flyte was studied in patients with stress urinary incontinence (SUI) in two key studies including a 60 patient study in Norway and a 119 patient study in the U.S., one of the largest of its kind for an in-home treatment.

Single-Center Study at Arctic University of Norway (60 patients)

  • 83% of patients were continent at 6 weeks
  • 77% of patients reported continence at 2 year follow-up (36 patients responded) 

Multi-Center, Randomized, Double-Blind, Controlled Study in United States (119 patients)

  • 71% of patients reported dry or near-dry results by 12 weeks — 37% of patients reported dry or near-dry results in as little as 2 weeks
  • Over 90% of women said Flyte is simple and easy to use (106 women surveyed) 

Flyte is proven to reduce bladder leaks - both frequency and volume.

Before starting therapy with Flyte, patients in our US clinical trial experienced bladder leaks daily – between 10 – 500 grams a day. Twelve weeks into clinical trial, patients saw a dramatic reduction in leaks, most leaking 0 – 10 grams.

The Norwegian study included patients of mild and moderate stress urinary incontinence severity, similar to most studies of conservative treatments.  The strong results are impressive and durable, with 83% of women continent in only 6 weeks, and 77% of women who responded to a 2-year follow-up question reporting continued continence.

The U.S. study included patients with severe stress urinary incontinence, which is rare for studies of conservative treatments.  Many conservative therapies perform poorly for women who have severe incontinence.  Flyte continued to perform well, with 37% of patients reporting dry or near-dry results in a little as 2 weeks, and 71% by 12 weeks.  With the inclusion of patients with severe incontinence, this is quite remarkable for a conservative treatment.

Clinical Trial People Graph 2

Flyte is proven to improve the quality of life for women with stress urinary incontinence.

90%

 

 

of users said Flyte is simple and easy to use (106 women surveyed)

87%

 

 

of users said Flyte was useful (106 women surveyed)

83%

 

 

of users would recommend Flyte to others (106 women surveyed)

Stop coping. Start treating at home.

(and say goodbye to all those pads!)

Subscribe to our Flyte Notes newsletter for articles, promotions and more

Something went wrong. Please check your entries and try again.